Press Releases

Press Releases

November 8, 2022
ORIC Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 7, 2022
ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
November 3, 2022
ORIC Pharmaceuticals to Present Preclinical Data on CD73 Inhibitor Program in Multiple Myeloma at the 64th American Society of Hematology (ASH) Annual Meeting
October 7, 2022
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 1, 2022
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
August 11, 2022
ORIC Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update
June 2, 2022
ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 17, 2022
ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
May 9, 2022
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
April 12, 2022
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
Displaying 1 - 10 of 17